ST‐Elevation Myocardial Infarction, Thrombus Aspiration, and Different Invasive Strategies. A TASTE Trial Substudy

Author:

Fröbert Ole1,Calais Fredrik1,James Stefan K.2,Lagerqvist Bo2

Affiliation:

1. Department of Cardiology, Faculty of Health, Örebro University, Sweden

2. Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Sweden

Abstract

Background The clinical effect of thrombus aspiration in ST ‐elevation myocardial infarction may depend on the type of aspiration catheter and stenting technique. Methods and Results The multicenter, prospective, randomized, open‐label trial Thrombus Aspiration in ST ‐Elevation myocardial infarction in Scandinavia ( TASTE ) did not demonstrate a clinical benefit of thrombus aspiration compared to percutaneous coronary intervention alone. We assessed the effect of type of aspiration device, stent type, direct stenting, and postdilatation on outcomes at 1 year. There was no difference in all‐cause mortality, between the 3 most frequently used aspiration catheters (Eliminate [Terumo] 5.4%, Export [Medtronic] 5.0%, Pronto [Vascular Solutions] 4.5%) in patients randomized to thrombus aspiration. There was no difference in mortality between directly stented patients randomized to thrombus aspiration compared to patients randomized to percutaneous coronary intervention only (risk ratio 1.08, 95% CI 0.70 to 1.67, P =0.73). Similarly, there was no difference in mortality between the 2 randomized groups for patients receiving drug‐eluting stents (risk ratio 0.89, 95% CI 0.63 to 1.26, P =0.50) or for those treated with postdilation (risk ratio 0.72, 95% CI 0.49 to 1.07, P =0.11). Furthermore, there was no difference in rehospitalization for myocardial infarction or stent thrombosis between the randomized arms in any of the subgroups. Conclusions In patients with ST ‐elevation myocardial infarction randomized to thrombus aspiration, the type of aspiration catheter did not affect outcome. Stent type, direct stenting, or postdilation did not affect outcome irrespective of treatment with thrombus aspiration and percutaneous coronary intervention or percutaneous coronary intervention alone. Clinical Trial Registration URL : ClinicalTrials.gov. Unique identifier: NCT 01093404, https://clinicaltrials.gov/ct2/show/NCT01093404 .

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3